Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women. (PANNA)

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2015 by Radboud University
Sponsor:
Collaborators:
PENTA Foundation
Merck Sharp & Dohme Corp.
Bristol-Myers Squibb
Janssen Pharmaceutica
Information provided by (Responsible Party):
Radboud University
ClinicalTrials.gov Identifier:
NCT00825929
First received: January 19, 2009
Last updated: January 9, 2015
Last verified: January 2015